Invus Financial Advisors’s Arcus Biosciences RCUS Stock Holding History

Invus Financial Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$24.6M	Hold	1,612,077	–	–	27.51%	2
2024 Q1	$30.4M	Hold	1,612,077	–	–	24.2%	2
2023 Q4	$30.8M	Hold	1,612,077	–	–	24.1%	2
2023 Q3	$28.9M	Hold	1,612,077	–	–	18.14%	3
2023 Q2	$32.7M	Hold	1,612,077	–	–	17.51%	3
2023 Q1	$29.4M	Hold	1,612,077	–	–	19.15%	2
2022 Q4	$33.3M	Hold	1,612,077	–	–	17.74%	2
2022 Q3	$42.2M	Hold	1,612,077	–	–	23.15%	2
2022 Q2	$40.9M	Hold	1,612,077	–	–	24.66%	1
2022 Q1	$50.9M	Hold	1,612,077	–	–	22.64%	2
2021 Q4	$65.2M	Sell	1,612,077 -230,000	-12%	-$8.92M	19.83%	2
2021 Q3	$64.2M	Hold	1,842,077	–	–	17.21%	3
2021 Q2	$50.6M	Hold	1,842,077	–	–	10.08%	4
2021 Q1	$51.7M	Hold	1,842,077	–	–	11.86%	2
2020 Q4	$47.8M	Hold	1,842,077	–	–	19.99%	3
2020 Q3	$31.6M	Hold	1,842,077	–	–	15.19%	4
2020 Q2	$45.6M	Hold	1,842,077	–	–	16.47%	3
2020 Q1	$25.6M	Hold	1,842,077	–	–	12.55%	4
2019 Q4	$18.6M	Buy	+1,842,077	New	+$15.5M	9.44%	4

Other funds holding RCUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Invus Financial Advisors's RCUS Position: Q2 2024 in Review

Invus Financial Advisors held its Arcus Biosciences (RCUS) position steady in Q2 2024 at 1,612,077 shares worth $24.6M. The position accounts for 27.51% of the portfolio, ranked #2.

Invus Financial Advisors first reported a position in RCUS in Q4 2019 and has held it in 19 quarters since. The position peaked at $65.2M in Q4 2021. 193 funds tracked by Wall St. Rank hold RCUS as of Q2 2024.

Invus Financial Advisors held 1,612,077 shares of Arcus Biosciences worth $24.6M as of Q2 2024.
Invus Financial Advisors left its Arcus Biosciences share count unchanged in Q2 2024.
Arcus Biosciences made up 27.51% of Invus Financial Advisors's portfolio in Q2 2024, its #2 holding.
Invus Financial Advisors first reported a position in Arcus Biosciences in Q4 2019 and has held it in 19 quarters since.
Invus Financial Advisors's Arcus Biosciences position peaked at $65.2M in Q4 2021.
193 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2024.

Based on Invus Financial Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.